Naprod Life Sciences took part in Pharma Eurasia 2026, held at Tashkent Pharma Park, Uzbekistan, at Stall D15 on 20–22 May 2026. The company’s announcement named delegates Rahul Chavan and Kamlesh Thakur as attending to connect with partners and explore opportunities across the Eurasian pharmaceutical market.
Why it matters
The Eurasian region, spanning the CIS and Central Asian markets, is served through regulatory frameworks that reference WHO-GMP-listed manufacturers, and, for the Eurasian Economic Union, through the EAEU GMP framework. Naprod holds an EAEU GMP certificate for its Tarapur site (covering Russia, Belarus, Kazakhstan, Armenia, and Kyrgyzstan), and participation at Pharma Eurasia supports its distributor and registration activity across these markets.
This is a company announcement, published on Naprod’s official LinkedIn page, and is presented here as a company update rather than an independently verified news report.